Sri Krishna, Sweta Mishra, Prakash Tiwari, Anup K Vishwakarma, Sushrikanta Khandai, Suyesh Shrivastava, Anil K Verma, Shashikant Tiwari, Hari Barman, Surendra Jhariya, Pradeep Tiwari, Anup S Tidgam, Brij M Varun, Sunil Singh, Naresh Yerane, Chintaman R Tembhurne, Prem L Mandavi, Shyam S Tekam, Manas Malik, Kali P Behera, Himanshu Jayswar, Khemraj Sonwani, Mukund S Diggikar, Madan M Pradhan, Sher S Khasotiya, Avdhesh Kumar, Neeraj Dhingra, Maria Dorina G Bustos, Eva-Maria Christophel, Pascal Ringwald, Roop Kumari, Man M Shukla, Neeru Singh, Aparup Das, Praveen K Bharti
BACKGROUND: Malaria is a major public health problem in India and accounts for about 88% of malaria burden in South-East Asia. India alone accounted for 2% of total malaria cases globally. Anti-malarial drug resistance is one of the major problems for malaria control and elimination programme. Artemether-lumefantrine (AL) is the first-line treatment of uncomplicated Plasmodium falciparum in north eastern states of India since 2013 after confirming the resistance against sulfadoxine-pyrimethamine...
May 21, 2021: Malaria Journal